Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable
Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.
verywellhealth17d
Common Types of Nasal Sprays — and How to Use Them
Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it incorrectly could affect the dose you receive. There are many OTC and ...
Healthline25d
Understanding Your Daily Insulin Needs
The University of California, San Francisco states that, as a general rule, 1 unit of rapid-acting insulin will process anywhere from 12 to 15 grams of carbohydrates. A bolus dose may also be used ...
Verywell Health on MSN9d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
thecardiologyadvisor.com4d
Nasal Spray Formulation of Bumetanide Under FDA Review
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Rolling Out12d
Alzheimer’s new nasal spray stops memory loss
The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...
Medscape14d
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...
Medical News Today11d
FDA-approved nasal spray for severe depression can lead to remission
Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.
AOL11d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...
PharmiWeb7d
Unit Dose Manufacturing Market to Surge to USD 193.3 Billion by 2034 with 3D Printing Innovations
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia, Middle East, and Africa have been covered in the report. About Future Market Insights (FMI) Future ...
WebMD11d
What to Know About the New Nasal Spray for Tough Depression
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...